How much funding has Ablexis raised?

Ablexis has raised $12.0M in total funding, most recently a Series A round.

Where is Ablexis headquartered?

Ablexis is headquartered in San Diego, California, United States.

What industry is Ablexis in?

Ablexis operates in Biotech, Healthcare.

Ablexis

Q: Who are Ablexis's investors?

Ablexis's investors include Deerfield Management, Third Rock Ventures, Pfizer Ventures.

Acquired

San Diego, United States · Founded 2009 · $12.0M raised

Biotech

Healthcare

Headquarters: San Diego, California
Founded: 2009
Business Model: B2B
Website: ablexis.com

Total Funding: $12.0M
Last Round: $12.0M Series AJun 2010
Rounds: 1

About

Founded in 2009, Ablexis is a biotechnology company that created the AlivaMab Mouse, a best-in-class transgenic mouse platform used by pharmaceutical and biotech partners to discover and develop human therapeutic antibodies. The company was built on technology developed at Aliva Biopharmaceuticals and is led by CEO Larry, a co-inventor of the XenoMouse technology with over 25 years of experience in transgenic antibody discovery. Ablexis licenses its AlivaMab Mouse platform to biopharmaceutical partners, with collaborations spanning major pharma companies such as Amgen, AstraZeneca, and Pfizer.

Summary

Ablexis is a Biotech company based in San Diego, United States, founded in 2009. It has raised $12.0M in total across 1 round, most recently a $12.0M Series A round in Jun 2010. Investors include Deerfield Management, Third Rock Ventures and Pfizer Ventures.